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We estimated the number of cancer cases and deaths attributable
to alcohol drinking in 2002 by sex and WHO subregion, based on
relative risks of cancers of the oral cavity, pharynx, esophagus,
liver, colon, rectum, larynx and female breast obtained from
recent meta- and pooled analyses and data on prevalence of
drinkers obtained from the WHO Global Burden of Disease pro-
ject. A total of 389,100 cases of cancer are attributable to alcohol
drinking worldwide, representing 3.6% of all cancers (5.2% in
men, 1.7% in women). The corresponding ﬁgure for mortality is
232,900 deaths (3.5% of all cancer deaths). This proportion is par-
ticularly high among men in Central and Eastern Europe. Among
women, breast cancer comprises 60% of alcohol-attributable can-
cers. Although our estimates are based on simpliﬁed assumptions,
the burden of alcohol-associated cancer appears to be substantial
and needs to be considered when making public health recommen-
dations on alcohol drinking.
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A causal link has been established between alcohol drinking
and cancers of the oral cavity, pharynx, esophagus, colon, rectum,
liver, larynx and breast.1 For other cancers, a causal association is
suspected.1
Despite the importance of alcohol as a human carcinogen,2,3 a
detailed estimate of the global burden of alcohol-related cancers is
lacking. We aimed to estimate the worldwide burden of alcohol-
related cancer by combining the relative risk of cancer with the
distribution of drinkers and the number of incident cases of cancer
and of deaths from cancer. Although cancer incidence is a more
relevant measure to estimate the burden of cancer, we have also
included mortality in our estimates because of the higher quality
of this type of data in many low- and medium-resources coun-
tries.4
Methods
We calculated the number of cases of cancer of the oral cavity
and pharynx, esophagus, colorectal, liver and larynx for both sexes
and for breast cancer for women. For each cancer site and each
WHO subregion (Table I), we obtained the age-speciﬁc distribu-
tion of drinkers among adults from the Global Burden of Disease
project.2 These distributions are based on surveys conducted in 69
countries. We considered 5 categories of drinkers: abstainers, and
drinkers of 1–19, 20–39, 40–59 and 60 and more grams of alco-
hol/day. We combined the ﬁrst 2 categories of drinkers for men,
and the last 2 categories for women. We obtained relative risks
(RR) for all cancers, but female breast cancer from a recent meta-
analysis.5 In this meta-analysis, the authors provided summary RR
estimates for intake of 25 g/day (used for the 20–39 g/day cate-
gory), 50 g/day (used for the 40–59 g/day category) and 75 g/day
(used for the 601 g/day category). For the 1–19 g/day category,
we estimated the excess risk to be half of that reported for the
25 g/day category (as the midpoint of the 1–19 g/day category lies
close to 25/2), and we estimated the excess risk for the 1–39 g/day
category in men to be 75% of that reported in the meta-analysis
for the 25 g/day category (as the midpoint of the 1–39 g/day cate-
gory lies close to 25 3 0.75). In the case of female breast cancer,
we used the results of a recent pooled analysis, which concluded
for a linear dose-response relationship with relative risk of 1.07
per 10 g/day of alcohol intake.6
We obtained the age-speciﬁc numbers of incident cases of can-
cer and of cancer deaths in 2002 from the Globocan 2002 project.4
We then calculated the numbers of cases (or deaths) attributable to
alcohol drinking (ACalc) in each sex according to the formulae:
ACalc ¼ RjkðAFjk
 NjkÞ
and
AFjk ¼ RiðPijk
ðRRi  1Þ=ðPijk
ðRRi  1Þ þ 1ÞÞ
where, for each category of drinking i, each age group j, and each
WHO subregion k, P is the proportion of drinkers, N is the number
of cases (or deaths) and AF is the attributable fraction. The RR
(reported in Table II) are speciﬁc for sex, but not for age or WHO
subregion. We used the same RR for cancer mortality and cancer
incidence (i.e., we assumed that alcohol drinking does not affect
cancer survival).
Results
Table III shows the overall results for cancer incidence: a total
of 389,100 cases of cancer were attributed to alcohol drinking
worldwide, representing 3.6% of all cancers (5.2% in men, 1.7%
in women). Among men, more than 60% of all alcohol-associated
cancers were from the upper digestive tract (oral cavity, pharynx
and esophagus); among women, about 60% of alcohol-associated
cancers were from the breast. Table IV reports comparable ﬁgures
for mortality: the proportions of attributable cancer deaths were
similar to those found for incidence, resulting in a total of 232,900
cancer deaths attributable to alcohol drinking (3.5% of all cancer
deaths).
In Figure 1 the alcohol-attributable fraction of overall cancer
incidence is presented for each WHO subregion: alcohol drinking
is responsible for a large proportion of cancer in Europe (in partic-
ular, in Central and Eastern Europe [Europe C]), America, East
Asia, Oceania and sub-Saharan Africa, while in Northern Africa,
and Western and Southern Asia this proportion is smaller. As
shown in Table V, the largest number of cases of alcohol-attributa-
ble cancer in men originates from Eastern Asia, in particular
China, and from Europe, while Europe and North America are the
regions with the largest contribution of alcohol-attributable can-
cers among women.
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Discussion
We found that 3.6% of all cases of cancer and a similar propor-
tion of cancer deaths are attributable to alcohol drinking. These
ﬁgures are higher in selected regions of the world, in particular in
Central and Eastern Europe. It is worth noting that among women
60% of cancers attributable to alcohol occur in the breast.
Our results are likely to represent a conservative estimate of the
burden of alcohol-associated cancer, since they are restricted to
cancers with an established association with alcohol drinking. An
association with alcohol drinking is suspected also for other types
of cancer, such as pancreatic, lung, bladder and kidney cancer.1
On the other hand, the estimate for head and neck and esophageal
cancers does not take into consideration the interaction between
TABLE I – WHO SUBREGIONS
Africa D Algeria, Angola, Benin, Burkina Faso, Cameroon, Cape Verde, Chad, Comoros Equatorial Guinea,
Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Madagascar, Mali, Mauritania, Mauritius,
Niger, Nigeria, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Togo
Africa E Botswana, Burundi, Central African Republic, Congo, Coˆte d’Ivoire, Democratic Republic of the Congo,
Eritrea, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, South Africa, Swaziland,
Uganda, United Republic of Tanzania Zambia, Zimbabwe
America A Canada, Cuba, United States of America
America B Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Brazil, Chile, Colombia, Costa Rica,
Dominica, Dominican Republic, El Salvador, Grenada, Guyana, Honduras, Jamaica, Mexico, Panama,
Paraguay, Saint Kitts and Newis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and
Tobago, Uruguay, Venezuela
America D Bolivia, Ecuador, Guatemala, Haiti, Nicaragua, Peru
Eastern Mediterranean B Bahrain, Cyprus, Iran (Islamic Republic of), Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Oman,
Qatar, Saudi Arabia, Syrian Arab Republic, Tunisia, United Arab Emirates
Eastern Mediterranean D Afghanistan, Djibouti, Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan, Yemen
Europe A Andorra, Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece,
Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino,
Slovenia, Spain, Sweden, Switzerland, United Kingdom
Europe B Albania, Armenia, Azerbaijan, Bosnia and Herzegovia, Bulgaria, Georgia, Kyrgyzstan, Poland,
Romania, Slovakia, Tajikistan, The Former Yugoslav Republic of Macedonia, Turkey, Turkmenistan,
Uzbekistan, Yugoslavia
Europe C Belarus, Estonia, Hungary, Kazakhstan, Latvia, Lithuania, Republic of Moldova, Russian Federation, Ukraine
South-East Asia B Indonesia, Sri Lanka, Thailand
South- East Asia D Bangladesh, Bhutan, Democratic People’s Republic of Korea, India, Maldives, Myanmar, Nepal, Timor Leste
Western Paciﬁc A Australia, Brunei Darussalam, Japan, New Zealand, Singapore
Western Paciﬁc B Cambodia, China, Cook Islands, Fiji, Kiribati, Lao People’s Democratic Republic, Malaysia,
Marshall Islands, Micronesia (Federated States of), Mongolia, Nauru, Niue, Palau,
Papua New Guinea, Philippines, Republic of Korea, Samoa, Solomon Islands, Tonga, Tuvalu,
Vanuatu, Viet Nam
TABLE II – RELATIVE RISKS USED IN THE ANALYSIS OF ATTRIBUTABLE FRACTIONS
Sex Drinking category Oral cav., pharynx Esophagus Colon, rectum Liver Larynx Breast
Men Abstainers1 1.00 1.00 1.00 1.00 1.00 NA
1–39 g/day 1.65 1.29 1.05 1.14 1.32 NA
40–59 g/day 3.11 1.93 1.12 1.40 2.02 NA
601 g/day 6.45 3.59 1.25 1.81 3.86 NA
Women Abstainers1 1.00 1.00 1.00 1.00 1.00 1.00
1–19 g/day 1.43 1.19 1.03 1.09 1.21 1.07
20–39 g/day 1.86 1.39 1.06 1.19 1.43 1.21
401 g/day 3.11 1.93 1.12 1.40 2.02 1.35
Reference [5] [5] [5] [5] [5] [6]
NA, not applicable.
1Reference category.
TABLE III – ALCOHOL-ATTRIBUTABLE CANCER CASES
WORLDWIDE BY SEX, 2002
Men Women Total
AF% Cases AF% Cases AF% Cases
Oral cavity,
pharynx
38.8 109,500 10.9 13,300 30.4 122,800
Esophagus 25.0 79,000 4.5 6,600 18.5 85,500
Colon and
rectum
4.6 25,200 1.7 7,800 3.2 33,000
Liver 12.2 53,800 2.9 5,400 9.4 59,100
Larynx 25.3 35,200 7.3 1,500 23.0 36,700
Breast
(women)
NA NA 4.5 51,900 4.5 51,900
Total 5.21 302,600 1.71 86,400 3.61 389,100
NA, not applicable. Numbers might not add up because of round-
ing. AF%, fraction of cancers attributable to alcohol drinking.
1Denominator comprises all cancer cases.
TABLE IV – ALCOHOL-ATTRIBUTABLE CANCER DEATHS
WORLDWIDE BY SEX, 2002
Men Women Total
AF% Deaths AF% Deaths AF% Deaths
Oral cavity,
pharynx
33.3 49,500 8.6 5,400 25.9 54,900
Esophagus 24.6 64,200 4.4 5,500 18.1 69,700
Colon and
rectum
4.4 12,300 1.6 4,000 3.1 16,300
Liver 12.1 50,600 3.0 5,500 9.4 56,100
Larynx 23.5 18,500 6.4 700 21.4 19,200
Breast
(women)
NA NA 4.1 16,800 4.1 16,800
Total 5.11 195,000 1.31 37,900 3.51 232,900
NA, not applicable. Numbers might not add up because of round-
ing. AF%, fraction of cancer deaths attributable to alcohol drinking.
1Denominator comprises all cancer deaths.
885BURDEN OF CANCER ATTRIBUTABLE TO ALCOHOL DRINKING
alcohol drinking and tobacco smoking in the etiology of these can-
cers.7 A sizable proportion of cases of cancers of the upper aerodi-
gestive tract can therefore be attributed to (i.e., can be prevented
by removing) either factor. Furthermore, in the case of lymphoma,
a protective effect has been suggested by some studies.8
Our estimates of the proportion of cancer cases and deaths at-
tributable to alcohol drinking are consistent among them. Minor
differences are explained by the fact that WHO subregions with
different survival rates contribute differently to the each cancer
site. For example, the burden of breast cancer in women is greater
for incidence (4.5%) than for mortality (4.1%), because a larger
proportion of incident cases as compared to deaths occur in
regions with better survival rates (e.g., North America and
Europe), which are also characterized by a higher prevalence of
drinking women.
In 1981, Doll and Peto estimated two thirds of head and neck
cancer deaths in the United States, as well as a lower proportion of
deaths from esophageal and liver cancers were attributable to alco-
hol drinking, which represented 3% of total cancers.3 The same
ﬁgure of 3% was reported by the Harvard Center for Cancer Pre-
vention in 1996, without a clear explanation on how it was
derived.9 Our results for the WHO subregion comprising the
United States (America A) concur with these estimates, but they
also indicate that the burden of alcohol-related cancer is likely to
be higher in other regions of the world.
Three studies have provided a detailed assessment of the burden
of alcohol-related cancers following an approach similar to ours.
In an exercise aimed to assess the burden of deaths in Australia in
1995 from tobacco, alcohol and other addictive substances, it was
estimated that 1.6% of total cancer deaths among men and 1.2%
among women are attributable to alcohol drinking.10 These esti-
mates are lower than ours (4.1% among men and 2.1% among
women in Western Paciﬁc A sub-region, Fig. 1), because they did
not consider colon and rectum among the target sites of alcohol
carcinogenesis and used older data reporting a lower prevalence of
drinkers. An estimate recently produced by the WHO Global Bur-
den of Disease project and based on relative risks and prevalence
data similar to ours resulted in an estimate of 355,000 cancer
deaths attributable to alcohol drinking in 20002: in that project,
however, no detailed results were reported for cancer type and ge-
ographic region. Similar estimates (351,000 deaths worldwide in
2001) were reported in a further analysis of the role of 9 cancer
risk factors, including alcohol drinking.11 Our estimates are more
conservative, in particular with respect to the role of alcohol
drinking in mortality from esophageal and liver cancers, 2 neo-
plasms responsible for a large number of deaths in populations
with limited alcohol consumption.
The regional differences in the burden of alcohol-attributable
cancer resulted from variations in the prevalence of drinking:
other potential sources of regional variability, including the carci-
nogenic effect of local alcoholic beverages and the pattern of
drinking––i.e., binge drinking––were not taken into consideration
because of uncertainties in the quantiﬁcation of the effect of such
factors on cancer risk. In any case, studies conducted in different
populations indicate that the most commonly used beverage is the
one most strongly related to risk in each population, i.e., spirits in
northern Europe and wine in southern Europe.12,13
Our results are limited by the quality of available data on risk of
cancer from alcohol drinking, prevalence of drinking and cancer
incidence and mortality. Although a causal association between
alcohol drinking and increased risk of cancer at several organs is
well established, the quantiﬁcation of the effect at different doses
is subject to more uncertainties and relies on results of epidemio-
logical studies, which may suffer from residual confounding
(notably by smoking for cancers of upper aerodigestive organs,
leading to an overestimate of the effect of alcohol), misclassiﬁca-
tion of past alcohol drinking (likely leading to an underestimate of
the same effect), as well as other sources of bias (leading to unpre-
dictable errors). It should be stressed that meta- and pooled-analy-
ses, while improving the precision of the risk estimates, do not
solve the problems of bias and confounding.
Several meta-analyses are available on the RR of speciﬁc can-
cers among drinkers.3,10,14–17. We have used the meta-analysis by
Corrao et al.5 because (i) it is recent, (ii) it includes all cancers that
we considered causally associated with alcohol drinking and (iii)
it provides RR for different levels of drinking.
FIGURE 1 – Alcohol-attributable
fraction (AF) of all cancers by sex
and WHO subregion (see Table I
for details on WHO subregions),
2002.
TABLE V – ALCOHOL-ATTRIBUTABLE CANCER CASES (ALL SITES)
BY SEX AND WHO SUBREGION, 2002
WHO subregion Men Women
Africa D 3,700 1,100
Africa E 10,800 2,300
America A 26,100 15,500
America B 17,900 7,000
America D 800 600
Eastern Mediterranean B 500 100
Eastern Mediterranean D 900 100
Europe A 67,400 30,500
Europe B 11,300 3,700
Europe C 30,500 9,000
South East Asia B 1,700 400
South East Asia D 11,800 1,000
Western Paciﬁc A 15,000 5,600
Western Paciﬁc B 104,300 9,700
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Data on prevalence of drinking were obtained from the WHO
Global Burden of Disease project2: these estimates are based on sur-
veys conducted in 69 countries, including at least one (usually the
largest) in each subregion, with the exception of the 2 Eastern Medi-
terranean subregions. Although these data suffer from variability in
precision, quality and other validity issues, they represent the only
comprehensive attempt to estimate the prevalence of alcohol drink-
ing worldwide. Data on cancer incidence and mortality were derived
from the IARC Globocan 2002 project.4While these data are reliable
for most high-resource and many medium-resource countries, data
from most low-resource countries are known to be of poor quality.
The burden of alcohol-associated cancer should be considered
in the light of the evidence that alcohol drinking modiﬁes the risk
of numerous other diseases, but a detailed quantiﬁcation of these
effects goes beyond the scope of our study. The major non-neo-
plastic diseases caused by alcohol drinking are mental disorders,
polyneuropathy, cardiomyopathy, hypertension, haemorragic
stroke, gastritis, liver cirrhosis and ﬁbrosis, and acute and chronic
pancreatitis. In addition, alcohol drinking is a major cause of sev-
eral types of injuries. On the other hand, there is strong evidence
that moderate consumption of alcohol reduces the risk of ischemic
heart disease, ischemic stroke and colelithiasis. A recent global
estimate of the burden of disease due to alcohol drinking sug-
gested that, in most populations, cancer is likely to represent an
important, albeit not predominant component of alcohol-related
morbidity and mortality.2
Our estimates required a number of simplifying assumptions:
the relative risks of alcohol-associated cancer may be modiﬁed by
smoking, ethnicity, age, and drinking patterns; in such case, differ-
ences in age structure, ethnicity, or smoking prevalence among
WHO subregions would modify our estimates of the number of
alcohol-attributable cancers. However, given the lack of deﬁnite
evidence on the effect modiﬁcation played by these covariates, we
have not attempted to use them in our estimates. The rates of can-
cer among abstainers may also be inﬂuenced by dietary habits that
are likely to differ in important ways from those who drink alco-
hol. This group may also include some individuals who were pre-
vious heavy consumers of alcohol, and it is plausible that the com-
position of these 2 types of abstainers will differ between WHO
subregions.
In conclusion, although our estimates are based on simpliﬁed
assumptions, a substantial number of cancer cases and cancer
deaths appear to be attributable to alcohol drinking. Although can-
cer is only one of the health effects of alcohol drinking, its role
needs to be kept in consideration when public health recommenda-
tions on drinking are made.
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